Evolent Health, Inc.
EVH
$27.24
$0.140.52%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 556.06M | 511.02M | 469.14M | 427.69M | 382.43M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 556.06M | 511.02M | 469.14M | 427.69M | 382.43M |
| Cost of Revenue | 454.43M | 386.59M | 351.94M | 310.48M | 299.37M |
| Gross Profit | 101.63M | 124.43M | 117.20M | 117.22M | 83.06M |
| SG&A Expenses | 65.18M | 85.94M | 78.73M | 77.43M | 65.46M |
| Depreciation & Amortization | 29.60M | 32.40M | 32.13M | 29.28M | 19.78M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 549.21M | 504.93M | 462.80M | 417.18M | 384.61M |
| Operating Income | 6.84M | 6.09M | 6.34M | 10.51M | -2.18M |
| Income Before Tax | -48.07M | -30.87M | -35.29M | -88.17M | -10.23M |
| Income Tax Expenses | -14.66M | -5.55M | -970.00K | -68.19M | 1.12M |
| Earnings from Continuing Operations | -33.41M | -25.32M | -34.32M | -19.98M | -11.35M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | 0.00 |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -33.41M | -25.32M | -34.32M | -19.98M | -11.35M |
| EBIT | 6.84M | 6.09M | 6.34M | 10.51M | -2.18M |
| EBITDA | 29.85M | 34.49M | 29.07M | 33.09M | 10.20M |
| EPS Basic | -0.36 | -0.30 | -0.37 | -0.24 | -0.11 |
| Normalized Basic EPS | 0.01 | -0.04 | -0.04 | -0.39 | -0.07 |
| EPS Diluted | -0.37 | -0.30 | -0.37 | -0.24 | -0.11 |
| Normalized Diluted EPS | 0.01 | -0.04 | -0.04 | -0.39 | -0.07 |
| Average Basic Shares Outstanding | 113.59M | 112.28M | 111.28M | 107.78M | 99.80M |
| Average Diluted Shares Outstanding | 113.59M | 112.28M | 111.28M | 107.78M | 99.80M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -15.45% | -20.12% | -14.23% | -18.27% | -- |
